-+ 0.00%
-+ 0.00%
-+ 0.00%

Plus Therapeutics Chief Development Officer Eric Daniels files initial beneficial ownership statement

PUBT·04/21/2026 21:00:49
Listen to the news
Plus Therapeutics Chief Development Officer Eric Daniels files initial beneficial ownership statement
  • Plus Therapeutics disclosed an initial Form 3 filing for Eric Joseph Daniels in his role as chief development officer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-167116), on April 21, 2026, and is solely responsible for the information contained therein.